Michael S Canney

Title: Michael S. Canney: Innovator in Drug Delivery Systems

Introduction

Michael S. Canney is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of medical technology, particularly in drug delivery systems. His innovative approach has led to the development of a unique device that enhances the administration of drugs directly into the brain fluid.

Latest Patents

Michael S. Canney holds a patent for an intraventricular access device designed for the infusion of drugs and aspiration of cerebrospinal fluid (CSF). This device allows for the direct infusion of drug solutions into the brain fluid, which can improve treatment efficacy. The device includes a container that couples to an aspiration lumen for CSF aspiration or drug injection. It also connects to an infusion lumen and a drug pump via a catheter, creating a pathway for drug infusion into the CSF. The design ensures that there is no cross-contamination between the fluids in the aspiration and infusion lumens. This innovative device has the potential to revolutionize how drugs are administered in neurological treatments.

Career Highlights

Michael S. Canney is currently employed at Biogen MA Inc., where he continues to work on advancing medical technologies. His career is marked by a commitment to improving patient outcomes through innovative solutions. With a focus on drug delivery systems, he has established himself as a key player in the medical device industry.

Collaborations

Michael has collaborated with notable colleagues, including Daniel J. Abrams and Md Daniel J. Abrams. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical technologies.

Conclusion

Michael S. Canney's contributions to the field of drug delivery systems exemplify the impact of innovation in medicine. His patented device for infusing drugs directly into brain fluid represents a significant advancement in treatment methodologies. Through his work at Biogen MA Inc. and collaborations with esteemed colleagues, he continues to push the boundaries of medical technology.